Moreover, the impact of shed CD138 extends beyond cell to cell contact within the tumor microenvironment as the accumulation of soluble CD138 enhances the growth of myeloma tumors in vivo and promotes endothelial invasion and angiogenesis (18, 19, 20). The gene discussed is SDC1; the disease is neoplasm.